← Back to Search

L-Phenylalanine for Phenylketonuria

N/A

Recruiting

Research Sponsored by University of Guelph

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to 2-hours post l-phe supplementation

Awards & highlights

Study Summary

This trial studies how an amino acid supplement affects mental health and cognition among people with and without a genetic disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Stop Signal Reaction Time (Response Inhibition)

Secondary outcome measures

Blood Pressure

Individual Coefficient of Variance (Variability in Reaction Times)

Mood

+6 more

Other outcome measures

Chronic Anxiety

Chronic Depression

Impulsivity

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Genetic Carriers and Non-Carriers of PKUExperimental Treatment1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of GuelphLead Sponsor

80 Previous Clinical Trials

9,966 Total Patients Enrolled

McMaster UniversityOTHER

880 Previous Clinical Trials

2,597,818 Total Patients Enrolled

Media Library

Genetic Carriers and Non-Carriers of PKU Clinical Trial Eligibility Overview. Trial Name: NCT05958784 — N/A

Phenylketonuria Research Study Groups: Genetic Carriers and Non-Carriers of PKU

Phenylketonuria Clinical Trial 2023: Genetic Carriers and Non-Carriers of PKU Highlights & Side Effects. Trial Name: NCT05958784 — N/A

Genetic Carriers and Non-Carriers of PKU 2023 Treatment Timeline for Medical Study. Trial Name: NCT05958784 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial have open enrollment at the present moment?

"Affirmative. Data from clinicaltrials.gov reveals that this medical investigation, first posted on July 1st 2023, is actively looking for patients to enroll in the trial. 10 volunteers are needed across a single site."

Answered by AI

How many individuals have been enlisted for this research endeavor?

"That is correct. The information available on clinicaltrials.gov reveals that the trial, which was first posted in July 1st 2023 and most recently updated on 14th of the same month, is actively looking for 10 participants from a single medical site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

PKU Carriers Trial (Pilot Study): Impact on Cognition, Mental Health, Blood Pressure and Metabolism

Justine Keathley 2023. "PKU Carriers Trial (Pilot Study): Impact on Cognition, Mental Health, Blood Pressure and Metabolism". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05958784.